Damora Therapeutics reported third quarter 2026 results with a net loss of US$31.99 million and continued progress on DMR-001 ...

Advanced Micro Devices Inc. expects its artificial intelligence business to deliver even stronger growth in 2027, with CEO ...

Bank of America’s upgrade of Constellation Brands (STZ) and the firm’s stronger than expected second quarter fiscal 2027 ...

Centuria Industrial REIT has delivered a 15.9% total return over the past three years, yet its current A$2.94 unit price ...

Management is betting on pricing changes and buyer behavior over near-term customer counts, a trade-off that likely defines ...

TD SYNNEX (SNX) has been in focus after unveiling expanded Destination AI tools tailored for small and mid-sized businesses, ...

AbCellera Biologics has produced a sharp year to date gain, which naturally raises a tougher question for anyone looking at ...

Why VNET Group’s Latest Quarter Is Moving the Stock VNET Group (VNET) is back in focus after its latest quarter combined 14.2 ...

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -64.87% and +9.43%, respectively, for the quarter ...

Keros Therapeutics (KROS) delivered earnings and revenue surprises of +172.92% and +197.47%, respectively, for the quarter ...

Clarus (NASDAQ:CLAR) raised its 2026 adjusted earnings outlook after third-quarter revenue growth and margin gains at its ...

Astrana Health (NASDAQ:ASTH) reported record third-quarter revenue and adjusted EBITDA as growth in Medicare Advantage ...